The recent disruptions in global chains have highlighted the value of securing vital medications like Ivermectin. Dependence on overseas manufacturers exposes nations to significant vulnerabilities, including transportation delays, price fluctuations, and even trade threats. Moving towards domestic procurement of Ivermectin offers a multitude of be